Correlation Engine 2.0
Clear Search sequence regions


The review describes the classification, mechanisms of action, the effects of calcium channel blockers slow and the clinical benefits of dihydropyridine calcium antagonists, the third generation. Presented modern aspects of clinical pharmacology and research results on the efficacy, safety and organoprotective lercanidipine.

Citation

M L Maksimov, A I Malykhina. Clinical cfficacy of calcium channel blockers slow the third generation of lercanidipine in the treatment of patients with arterial hypertension]. Kardiologiia. 2013;53(6):85-90

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 23953051

View Full Text